EnginZyme Produces Key mRNA Vaccine Ingredient Using Biocatalysis

Contributed by: Business Wire

Logo

Tags

Chemicals/Plastics

Retail

Manufacturing

Technology

Pharmaceutical

Supply Chain Management

Infectious Diseases

Artificial Intelligence

Transport

Science

Biotechnology

Logistics/Supply Chain Management

Health

Research

Medical Supplies

Vaccines

More Like This

PR Newswire associated0

Zymo Research Pioneers a Breakthrough in Large-scale Animal-free RNase A Production

TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase

Omniose Announces Scientific Collaboration With AstraZeneca to Research Vaccines for Serious Bacterial Diseases

TriLink BioTechnologies® Cuts Ribbon on New San Diego Facility for Late Phase mRNA Drug Substance Production (Photo: TriLink BioTechnologies®)

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

ACCESS Newswire associated0

Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program

PR Newswire associated0

Ajinomoto Bio-Pharma Services Garners Six 'CDMO Leadership Awards,' Further Establishing Its Industry Excellence

Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned

Argobio and the Institut Pasteur Launch Enodia Therapeutics: A Biotech Company With a New Approach for Targeted Protein Degradation